Document is current
Any future updates will be listed below
-
Authors
Fisch-Shvalb, Naama https://orcid.org/0000-0001-9612-6983
Zur, Maya
Lazar, Liora
Shamir, Raanan
Phillip, Moshe
Yackobovitch-Gavan, Michal
- License Information
-
More Information
Article History
Received: 22 May 2024
Revised: 13 September 2024
Accepted: 22 October 2024
First Online: 6 November 2024
Competing interests
: M.P. is chief scientific officer in Nutritional Growth Solutions (NGS) as well as owns stock and options in the company. R.S. is chief medical officer and board director in NGS as well as owns stock and options in the company. M.Y.G. is director of clinical studies in NGS as well as owns stock and options in the company.
: Written informed consent was obtained from parents of the participants prior to enrollment of the case groups, and verbal consent was obtained from the parents of the participants in the control groups, in compliance with the approval of the Institutional Review Board.
